Researchers have made DNA storage rewritable, overcoming one of its biggest limitations. The breakthrough could turn DNA into ...

Around the world, scientists are exploring an unexpected solution to the growing data crisis: storing digital information in ...

In a major shift in its hardware strategy, OpenAI launched GPT-5.3-Codex-Spark, its first production AI model deployed on ...

I’m a traditional software engineer. Join me for the first in a series of articles chronicling my hands-on journey into AI ...

Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven ...

The M5Stack AI Pyramid Computing Box is a small computer with an Axera AX88500 processor that combines four Arm Cortex-A55 CPU cores with an NPU that delivers up to 24 TOPS of hardware-accelerated ...

An oscilloscope is usually the most sensitive, and arguably most versatile, tool on a hacker’s workbench, often taking billions of samples per second to produce an accurate and informative ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...

The Mac Mini has consistently been a favorite among users for its compact design, affordability, and ability to balance performance with value. Now, leaks surrounding the 2026 Mac Mini suggest that ...

This year, about 45 percent of the revenues at Big Blue will come from software. But IBM wants to push this up to half of revenues and then onwards from there. IBM also wants to find the modern AI era ...

Strategy (MSTR) on Monday announced a further 25 basis point increase in the dividend rate of its STRC preferred series to 10.75%. This is the fourth increase since the IPO launch at the end of July.

A U.S. neurotechnology startup called Paradromics is gaining momentum in the fast-growing field of brain-computer interfaces. The FDA has approved its first human trial built to test whether its fully ...